Pages with the most revisions

Showing below up to 50 results in range #801 to #850.

801. Drug intoxication‏‎ (1 revision)
802. 6. Caseous necrosis and adiponecrosis‏‎ (1 revision)
803. 18. Development of the diencephalon and the telencephalon. Development of the commissural pathways and the fornix‏‎ (1 revision)
804. 40. Atrial or ventricular flutter, atrial or ventricular fibrillation‏‎ (1 revision)
805. 28. Epidemiology and prevention of depression and mood disorders‏‎ (1 revision)
806. Nephroptosis‏‎ (1 revision)
807. Enterography‏‎ (1 revision)
808. B3. Trochanteric, diaphyseal and distal fractures of the femur‏‎ (1 revision)
809. A21. Cutaneous and mucosal manifestations and treatment of syphilis‏‎ (1 revision)
810. 6. Utilization of nutrients and its disorders. Maldigestions. Age-dependent features of nutrient utilization‏‎ (1 revision)
811. 18A. Migraine and other primary headaches‏‎ (1 revision)
812. 41. Drugs used to treat bronchial asthma‏‎ (1 revision)
813. Ultrasonography‏‎ (1 revision)
814. B37. Peritonitis: Causes, therapy, complications‏‎ (1 revision)
815. A3. Urologic laboratory examination. Urinalysis and urine culture‏‎ (1 revision)
816. 19. Pharmacology of protein and peptide mediators, the purinergic system and nitric oxide‏‎ (1 revision)
817. 10. Bowel obstruction (ileus)‏‎ (1 revision)
818. 42. Nuclear medicine methods in childhood (kidney, bone, 123I-MIBG scintigraphy).‏‎ (1 revision)
819. 29A. Restless-legs syndrome‏‎ (1 revision)
820. Urticarial vasculitis‏‎ (1 revision)
821. Osteosarcoma‏‎ (1 revision)
822. Functional bowel disorder‏‎ (1 revision)
823. B47. Palliative surgery in pancreatic and periampullary tumors.‏‎ (1 revision)
824. A6. Postmenopausal bleeding‏‎ (1 revision)
825. 64. Vascular diseases of the lung‏‎ (1 revision)
826. 2. Characterisation of agonist-receptor interaction. Occupancy, affinity, dose-response curve, potency, efficacy‏‎ (1 revision)
827. 10. T-cell activation and peripheral T-cell differentiation‏‎ (1 revision)
828. Paranasal sinus tumour‏‎ (1 revision)
829. Glucose 6-phosphate dehydrogenase (G6PD) deficiency‏‎ (1 revision)
830. B6. Infectious diseases during pregnancy (hepatitis, HIV, toxoplasmosis, syphilis, Group B Streptococcus)‏‎ (1 revision)
831. A9. Autoimmune bullous skin diseases‏‎ (1 revision)
832. 67. Oliguria, polyuria. Renal functions in the elderly‏‎ (1 revision)
833. 2. The fundamentals of CT and MRI imaging, examination methods.‏‎ (1 revision)
834. 11. Diseases of the aorta. Imaging methods, the role of CT and MRI.‏‎ (1 revision)
835. 45. Causes and clinical consequences of hyperplasia and atrophy of the suprarenal gland. Cortical tumours of the suprarenal gland (morphology, clinical syndromes) Cortical insufficiency of the suprarenal gland. Tumors of the adrenal medulla.‏‎ (1 revision)
836. 30. Hodgkin lymphoma‏‎ (1 revision)
837. Periampullary cancer‏‎ (1 revision)
838. Hammer toe‏‎ (1 revision)
839. B9. Paraneoplastic skin disorders‏‎ (1 revision)
840. 7. Complications of suppurative otitis media‏‎ (1 revision)
841. 20. Nephrosis syndrome: minimal change, membranous glomerulonephritis, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis.‏‎ (1 revision)
842. 111. Risk assessment, management, and communication‏‎ (1 revision)
843. 46. Local anaesthetics‏‎ (1 revision)
844. 31. Epidemiology and prevention of addictions‏‎ (1 revision)
845. Phototherapy‏‎ (1 revision)
846. Hernia‏‎ (1 revision)
847. Acute lymphoblastic leukaemia‏‎ (1 revision)
848. 70. Mechanisms and disturbances of bone remodeling. Osteoporosis, osteomalacia‏‎ (1 revision)
849. 32. Demographic indicators: measures of mortality‏‎ (1 revision)
850. Popliteal cyst‏‎ (1 revision)